Cereno Scientific AB (publ) (STO:CRNO.B)
5.41
-0.40 (-6.89%)
At close: Jun 15, 2026
Cereno Scientific AB Revenue
Cereno Scientific AB had revenue of 38.97M SEK in the quarter ending March 31, 2026, with 137.29% growth. This brings the company's revenue in the last twelve months to 66.82M, down -11.75% year-over-year. In the year 2025, Cereno Scientific AB had annual revenue of 44.27M, down -45.28%.
Revenue (ttm)
66.82M
Revenue Growth
-11.75%
P/S Ratio
25.25
Revenue / Employee
6.68M
Employees
10
Market Cap
1.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.27M | -36.63M | -45.28% |
| Dec 31, 2024 | 80.90M | 31.63M | 64.18% |
| Dec 31, 2023 | 49.28M | -8.26M | -14.36% |
| Dec 31, 2022 | 57.54M | 12.73M | 28.42% |
| Dec 31, 2021 | 44.81M | 36.58M | 444.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioGaia AB | 1.54B |
| EQL Pharma AB | 432.66M |
| Cinclus Pharma Holding AB | 67.51M |
| Nanexa AB | 54.41M |
| Enzymatica AB | 53.06M |
| Newbury Pharmaceuticals AB | 32.78M |
| Orexo AB | 17.80M |
| Moberg Pharma AB | 14.59M |
Cereno Scientific AB News
- 20 days ago - Cereno Scientific AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Cereno Scientific AB Quarterly report: Q4 2025 - Filings
- 3 months ago - Cereno Scientific AB Annual report: Q4 2025 - Filings
- 4 months ago - Cereno Scientific AB Transcript: CMD 2026 - Transcripts
- 7 months ago - Cereno Scientific AB Quarterly report: Q3 2025 - Filings
- 9 months ago - Cereno Scientific AB Transcript: GoCo Investor Days - Transcripts
- 10 months ago - Cereno Scientific AB Quarterly report: Q2 2025 - Filings